DK1571923T3 - Præbiotiske sammensætninger - Google Patents

Præbiotiske sammensætninger Download PDF

Info

Publication number
DK1571923T3
DK1571923T3 DK03785796.8T DK03785796T DK1571923T3 DK 1571923 T3 DK1571923 T3 DK 1571923T3 DK 03785796 T DK03785796 T DK 03785796T DK 1571923 T3 DK1571923 T3 DK 1571923T3
Authority
DK
Denmark
Prior art keywords
composition
weight
fos
gos
compositions
Prior art date
Application number
DK03785796.8T
Other languages
English (en)
Inventor
Glenn R Gibson
Sofia Kolida
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9949583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1571923(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of DK1571923T3 publication Critical patent/DK1571923T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (15)

1. Næringsmiddel- eller farmaceutisk sammensætning omfattende fructooligosaccharid (FOS) og galactooligosaccharid (GOS), hvor vægtforholdet FOS:GOS er fra 0,5 til 2, og hvor mængden af FOS- og GOS-blandingen er mellem 0,05 og 40 vægtprocent, baseret på sammensætningens totalvægt.
2. Sammensætningen ifølge krav 1, hvor FOS indeholder op til 95 vægtprocent oligofructose sammensat af kæder med en polymerisationsgrad i området fra 2 til 7 og GOS indeholdende op til 95 vægtprocent oligogalactose sammensat af kæder med en polymerisationsgrad i området fra 2 til 7.
3. Sammensætning ifølge et hvilket som helst af de foregående krav der er en højkaloriesammensætning.
4. Sammensætning ifølge et hvilket som helst af de foregående krav der omfatter mere end 1 vægtprocent protein, baseret på sammensætningens totale kalorieindhold.
5. Sammensætning ifølge et hvilket som helst af de foregående krav der er en fuldstændig formeldiæt.
6. Sammensætning ifølge et hvilket som helst af de foregående krav der omfatter, pr. 100 ml: fra 1 til 3 g FOS, fra 1 til 3 g GOS, fra 2 til 20 g proteiner, fra 1 til 30 g kulhydrater, fra 0,5 til 20 g fedt, såvel som mineraler og vitaminer.
7. Sammensætning ifølge krav 6 der omfatter, per 100ml: 1,25 g FOS, 1,25 g GOS, 9 g proteiner, 22 g kulhydrater og 9 g fedt.
8. Sammensætning ifølge et hvilket som helst af de foregående krav der er en klar-til-brug sammensætning.
9. Sammensætning ifølge et hvilket som helst af kravene 1 til 4 til anvendelse som medikament.
10. Sammensætning ifølge et hvilket som helst af kravene 1 til 9, yderligere omfattende glutamin.
11. Anvendelse af en sammensætning ifølge et hvilket som helst af kravene 1 til 10 til fremstillingen af et medikament eller næringsmiddelsammensætning til behandling eller forebyggelse af gastrointestinale forstyrrelser, såsom diarré og forstoppelse.
12. Anvendelse af en sammensætning ifølge et hvilket som helst af kravene 1 til 10 til fremstillingen af et medikament eller en næringsmiddelsammensætning til opretholdelse og/eller genoprettelse af tarmfloraen.
13. Anvendelse af en sammensætning ifølge et hvilket som helst af kravene 1 til 10 til fremstillingen af et medikament eller næringsmiddelsammensætning til forebyggelsen eller behandling af inflammatorisk tarmsygdom, især ulcerativ colitis, Crohn's sygdom, og/eller til forebyggelse af tarmcancer.
14. Anvendelse af en sammensætning ifølge et hvilket som helst af kravene 1 til 10 til fremstillingen af et medikament eller en næringsmiddelsammensætning til stimulering af væksten af bifidobakterier og/eller lactobacilli og/eller inhibering af væksten af mindst én af: bacteroides, Clostridia, coliform, sulfatnedsættende bakterier.
15. Anvendelse af en sammensætning ifølge et hvilket som helst af kravene 1 til 10 til fremstillingen af et medikament eller en næringsmiddelsammensætning til forebyggelsen eller behandling af infektion med patogene tarmbakterier.
DK03785796.8T 2002-12-12 2003-12-11 Præbiotiske sammensætninger DK1571923T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0229015.3A GB0229015D0 (en) 2002-12-12 2002-12-12 New Compound
PCT/EP2003/014087 WO2004052121A1 (en) 2002-12-12 2003-12-11 Prebiotic compositions

Publications (1)

Publication Number Publication Date
DK1571923T3 true DK1571923T3 (da) 2014-02-17

Family

ID=9949583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03785796.8T DK1571923T3 (da) 2002-12-12 2003-12-11 Præbiotiske sammensætninger

Country Status (19)

Country Link
US (2) US7794746B2 (da)
EP (1) EP1571923B1 (da)
JP (1) JP4491348B2 (da)
CN (1) CN1731938B (da)
AU (1) AU2003294835B2 (da)
BR (1) BRPI0317272B1 (da)
CA (1) CA2508693C (da)
DK (1) DK1571923T3 (da)
ES (1) ES2449016T3 (da)
GB (1) GB0229015D0 (da)
HK (1) HK1083054A1 (da)
MX (1) MXPA05006266A (da)
NZ (1) NZ540576A (da)
PL (1) PL213665B1 (da)
PT (1) PT1571923E (da)
RU (1) RU2358474C2 (da)
TW (1) TWI337080B (da)
WO (1) WO2004052121A1 (da)
ZA (1) ZA200504385B (da)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US7608291B2 (en) * 2000-03-10 2009-10-27 Mars, Inc. Treatment of infection in animals
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
DE10328180A1 (de) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Verwendung von Isomalt als Präbiotikum
JP4384656B2 (ja) * 2003-06-30 2009-12-16 クラサド インコーポレイテッド 新規のガラクトシダーゼ酵素活性を生じさせるビフィドバクテリウムビフィダムの新規株
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
EP1629727A1 (en) 2004-08-24 2006-03-01 N.V. Nutricia Composition containing fermentable polysaccharides
WO2006035979A1 (ja) * 2004-09-29 2006-04-06 Asama Chemical Co., Ltd. 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品
RU2442438C2 (ru) * 2005-02-21 2012-02-20 Нестек С.А. Смесь олигосахаридов
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
RU2450815C2 (ru) * 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
GB0525857D0 (en) * 2005-12-20 2006-02-01 Product and process
GB0601901D0 (en) * 2006-01-31 2006-03-08 Product and Process
GB0606112D0 (en) 2006-03-28 2006-05-03 Product and process
CA2652735C (en) * 2006-05-30 2015-07-28 Nutrition Sciences N.V./S.A. Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
SI2076271T1 (sl) * 2006-10-02 2011-12-30 Friesland Brands Bv Inhibicija toksinov kolere z galatooligosaharidi (GOS)
CN101594879B (zh) * 2007-01-26 2012-06-20 天野酶株式会社 酶组合物及其用途
IL181431A0 (en) * 2007-02-19 2007-07-04 Micha Shemer Fruit juice and puree with a lowered amount of available sugars
WO2009032874A2 (en) 2007-09-06 2009-03-12 The Coca-Cola Company Systems and methods for providing portion control programming in a product forming dispenser
WO2009032875A2 (en) 2007-09-06 2009-03-12 The Coca-Cola Company Systems and methods for monitoring and controlling the dispense of a plurality of product forming ingredients
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
PL2589302T3 (pl) * 2007-12-21 2017-05-31 N.V. Nutricia Zastosowanie sfingomieliny i niestrawnych węglowodanów do poprawiania mikroflory jelitowej
JP5819041B2 (ja) * 2008-01-10 2015-11-18 ニュートリー株式会社 高齢者の栄養状態の改善、発熱回数の低下及び／又は免疫能向上のための組成物
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
AR072142A1 (es) 2008-06-13 2010-08-11 Nutricia Nv Nutricion para prevenir infecciones.proceso. composicion. uso.
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
CN101503720B (zh) * 2009-02-24 2011-08-24 中国海洋大学 一种具有益生元作用的微生物寡糖的制备方法
AU2010223965A1 (en) * 2009-03-13 2011-10-06 Dsm Food Specialties Usa Inc. Prebiotic oligosaccharides
WO2010106384A1 (fr) * 2009-03-16 2010-09-23 Societe La Biochimie Appliquee (Solabia) Compositions nutraceutiques, pharmaceutiques ou alimentaires a base de gluco-oligosaccharides
WO2010117274A1 (en) * 2009-04-08 2010-10-14 Stichting Top Institute Food And Nutrition Carbohydrates enhancing the production of a c5 and/or a c6 scfa
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
AU2009347008B2 (en) * 2009-05-27 2013-08-15 Clasado Limited Method of preventing diarrhoea
WO2010143940A1 (en) * 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
ES2622091T5 (es) 2009-08-18 2020-10-19 Cosucra Groupe Warcoing Sa Composiciones que contienen mezclas de fibras fermentables
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
WO2011093907A1 (en) * 2010-02-01 2011-08-04 Corn Products International, Inc. High-purity galactooligosaccharides and uses thereof
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2608678A1 (en) 2010-08-25 2013-07-03 Tate & Lyle Ingredients Americas LLC Synbiotic product
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
EP2478779A1 (en) 2011-01-24 2012-07-25 Biotechnobel Composition for providing beneficial health effects
CN102613294A (zh) * 2011-01-31 2012-08-01 内蒙古蒙牛乳业（集团）股份有限公司 一种低聚糖牛乳
JP5837315B2 (ja) * 2011-03-25 2015-12-24 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
EP2517699A1 (en) 2011-04-29 2012-10-31 Biotechnobel SA Composition for prevention and treatment of arthritis
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US9997006B2 (en) 2011-08-26 2018-06-12 Elwha Llc Treatment system and method for ingestible product dispensing system and method
US20130054255A1 (en) * 2011-08-26 2013-02-28 Elwha LLC, a limited liability company of the State of Delaware Controlled substance authorization and method for ingestible product preparation system and method
US9111256B2 (en) 2011-08-26 2015-08-18 Elwha Llc Selection information system and method for ingestible product preparation system and method
US8892249B2 (en) 2011-08-26 2014-11-18 Elwha Llc Substance control system and method for dispensing systems
US20130330447A1 (en) 2012-06-12 2013-12-12 Elwha LLC, a limited liability company of the State of Delaware Substrate Structure Deposition Treatment System And Method For Ingestible Product System and Method
US10121218B2 (en) 2012-06-12 2018-11-06 Elwha Llc Substrate structure injection treatment system and method for ingestible product system and method
US10192037B2 (en) 2011-08-26 2019-01-29 Elwah LLC Reporting system and method for ingestible product preparation system and method
US9785985B2 (en) 2011-08-26 2017-10-10 Elwha Llc Selection information system and method for ingestible product preparation system and method
US8989895B2 (en) 2011-08-26 2015-03-24 Elwha, Llc Substance control system and method for dispensing systems
US9037478B2 (en) 2011-08-26 2015-05-19 Elwha Llc Substance allocation system and method for ingestible product preparation system and method
US9922576B2 (en) 2011-08-26 2018-03-20 Elwha Llc Ingestion intelligence acquisition system and method for ingestible material preparation system and method
US9240028B2 (en) 2011-08-26 2016-01-19 Elwha Llc Reporting system and method for ingestible product preparation system and method
US10026336B2 (en) 2011-08-26 2018-07-17 Elwha Llc Refuse intelligence acquisition system and method for ingestible product preparation system and method
US20130330451A1 (en) 2012-06-12 2013-12-12 Elwha LLC, a limited liability company of the State of Delaware Substrate Structure Duct Treatment System and Method for Ingestible Product System and Method
US9947167B2 (en) 2011-08-26 2018-04-17 Elwha Llc Treatment system and method for ingestible product dispensing system and method
CN113662199A (zh) 2011-08-29 2021-11-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
RU2473347C1 (ru) * 2011-11-09 2013-01-27 Сергей Константинович Панюшин Композиция пребиотиков для нормализации микрофлоры организма
RU2484828C1 (ru) * 2012-04-11 2013-06-20 Анна Викторовна Филимонова Витаминно-минеральное средство: порошок для приготовления раствора для внутреннего применения
CN104487078A (zh) * 2012-05-18 2015-04-01 N·V·努特里奇亚 与真菌毒素暴露相关的病症的治疗
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN102861108B (zh) * 2012-09-07 2013-12-25 李宁 一种用于治疗便秘的药物组合物及其应用
US20140122120A1 (en) * 2012-10-30 2014-05-01 Pacesetter, Inc. Systems and methods for providing photo-based patient verification for use with implantable medical device programmers
US10626460B2 (en) 2013-02-21 2020-04-21 Children's Hospital Medical Center Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
GB201312713D0 (en) 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CA2966074A1 (en) * 2013-11-05 2016-05-12 Optibiotix Limited Prebiotic composition and its method of production
BR112017000345B1 (pt) 2014-07-09 2022-04-26 Cadena Bio, Inc Composições de oligossacarídeo, métodos para produção das mesmas e produto alimentar
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
ES2659648T3 (es) 2015-01-26 2018-03-16 Kaleido Biosciences, Inc. Compuestos terapéuticos de glicano y métodos relacionados de los mismos
MX2017013562A (es) * 2015-04-23 2018-05-28 Kaleido Biosciences Inc Reguladores de microbioma y usos relacionados de los mismos.
CN107771083A (zh) * 2015-04-23 2018-03-06 卡莱多生物科技有限公司 聚糖治疗剂和治疗方法
WO2016176484A1 (en) 2015-04-28 2016-11-03 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
GB201509023D0 (en) * 2015-05-27 2015-07-08 Optibiotix Ltd Compositions and methods of production thereof
US20180085384A1 (en) * 2015-06-23 2018-03-29 Nestec S.A. Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children
EP3334437A1 (en) * 2015-08-25 2018-06-20 Kaleido Biosciences, Inc. Glycan compositions and uses thereof
AU2015410635B2 (en) 2015-09-29 2021-08-19 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
CN105287561A (zh) * 2015-11-25 2016-02-03 上海交通大学医学院附属瑞金医院 一种治疗溃疡性结肠炎的药物组合物
EP3850953B1 (en) * 2016-06-10 2023-11-01 N.V. Nutricia Nutrition to reduce the risk of allergy
CN109689067A (zh) * 2016-07-13 2019-04-26 卡莱多生物科技有限公司 聚糖组合物和使用方法
CN107927775A (zh) * 2017-10-31 2018-04-20 天津市益倍建生物技术有限公司 一种含白藜芦醇的治疗溃疡性结肠炎的组合物
CN107981359A (zh) * 2017-12-12 2018-05-04 河北三元食品有限公司 益生元组合物及其应用
CN107912589A (zh) * 2017-12-21 2018-04-17 广州莱可福生物科技有限公司 含益生菌且可改善肠道和免疫力的压片糖果及其制备方法
CN108338984A (zh) * 2018-02-26 2018-07-31 量子高科(中国)生物股份有限公司 具有清肠作用的组合物及其制备方法和在碳水化合物组件特医配方食品中的应用
EP3542641B1 (de) 2018-03-20 2023-07-12 Universität Hohenheim Lactulosehaltiges produkt sowie verfahren zur herstellung eines lactulosehaltigen produkts
EP3877424A2 (en) 2018-11-08 2021-09-15 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof
WO2020130775A1 (es) * 2018-12-18 2020-06-25 Centro De Retina Médica Y Quirúrgica, S.C. Formulación de suplemento simbiótico para mejorar la microbiota intestinal
CN110237092A (zh) * 2019-06-11 2019-09-17 厦门蓝特生物科技有限公司 一种治疗便秘的组合物
CN112806577B (zh) * 2019-11-15 2021-11-26 内蒙古伊利实业集团股份有限公司 产丁酸的益生元益生菌增效组合
JP7010509B2 (ja) * 2020-01-15 2022-01-26 一般社団法人 Unical 新規配合スポーツ飲料およびその調製のための顆粒剤
CN112641098A (zh) * 2020-12-15 2021-04-13 山东欣瑞文生物科技有限公司 一种具有调理肠胃腹泻功能的阿拉伯胶组合物
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04311384A (ja) 1991-04-11 1992-11-04 Calpis Food Ind Co Ltd:The 植物組織培養方法及び植物組織培養用生長促進剤
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
WO1997000075A1 (fr) 1995-06-14 1997-01-03 Institute Of Immunology Co., Ltd. Medicament contre le prurit cutane accompagnant l'insuffisance renale
EP1254664A3 (en) 1995-07-10 2004-01-02 Abbott Laboratories Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans
US5827526A (en) 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
ES2123903T5 (es) 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
CN1211189A (zh) 1996-02-14 1999-03-17 普罗克特和甘保尔公司 含衍自杜鹃花科植物的物质和乳酸菌生长因子的,用于泌尿生殖系统和肠道疾病的组合物
JP4008974B2 (ja) * 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
HU223336B1 (hu) 1996-12-20 2004-06-28 Nutrinova Nutrition Specialties & Food Ingredients Gmbh. Oligoszacharidok alkalmazása aceszulfám-K/aszpartám keverék édességének és ízességének javítására
AU754615B2 (en) * 1997-07-05 2002-11-21 Australasian Food Group Pty Ltd Frozen dessert
JPH11302182A (ja) 1998-04-16 1999-11-02 Otsuka Pharmaceut Co Ltd 抗水虫組成物
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
ATE283697T1 (de) 2000-03-01 2004-12-15 Nestle Sa Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
EP1175905A1 (en) 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
JP2002051731A (ja) 2000-08-11 2002-02-19 Toyo Shinyaku:Kk 麦若葉由来の素材を含む便秘改善食品
GB0028238D0 (en) 2000-11-20 2001-01-03 Cerestar Holding Bv Indigestible oligosaccharides and magnesium absorption in humans
JP2004520318A (ja) 2000-12-27 2004-07-08 エヌ・ヴイ・ヌートリシア オリゴ糖を含有する健康増進作用を有する栄養組成物
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
JP4311384B2 (ja) 2005-08-09 2009-08-12 日産自動車株式会社 ハイブリット車両の発電制御方法

Also Published As

Publication number Publication date
PL213665B1 (pl) 2013-04-30
JP2006509797A (ja) 2006-03-23
US20040131659A1 (en) 2004-07-08
CN1731938A (zh) 2006-02-08
CN1731938B (zh) 2011-12-28
EP1571923A1 (en) 2005-09-14
NZ540576A (en) 2007-03-30
CA2508693C (en) 2013-08-13
HK1083054A1 (en) 2006-06-23
JP4491348B2 (ja) 2010-06-30
RU2005121665A (ru) 2006-04-27
PT1571923E (pt) 2014-03-28
US20110003768A1 (en) 2011-01-06
US7794746B2 (en) 2010-09-14
WO2004052121A1 (en) 2004-06-24
BR0317272A (pt) 2005-11-08
AU2003294835A1 (en) 2004-06-30
MXPA05006266A (es) 2005-08-19
GB0229015D0 (en) 2003-01-15
ZA200504385B (en) 2006-07-26
PL377411A1 (pl) 2006-02-06
US8241658B2 (en) 2012-08-14
EP1571923B1 (en) 2014-01-22
AU2003294835B2 (en) 2007-05-03
TWI337080B (en) 2011-02-11
ES2449016T3 (es) 2014-03-17
CA2508693A1 (en) 2004-06-24
BRPI0317272B1 (pt) 2016-03-22
RU2358474C2 (ru) 2009-06-20
TW200505462A (en) 2005-02-16

Similar Documents

Publication Publication Date Title
DK1571923T3 (da) Præbiotiske sammensætninger
EP1613180B1 (en) Synbiotic combination
ES2702631T3 (es) Composición nutricional con prebióticos y probióticos
EP2230943B1 (en) Paediatric fibre mixture
RU2475051C2 (ru) Детское питание с нежизнеспособными бифидобактериями и неусвояемыми олигосахаридами
EP1957084B1 (en) Composition containing oligosaccharides for the treatment / prevention of fever and febrile seizures
TW201233334A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
WO2023176952A1 (ja) 腸管内での細菌の増殖制御用組成物及びその利用